Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 784

1.

Fasting-Refeeding Impacts Immune Cell Dynamics and Mucosal Immune Responses.

Nagai M, Noguchi R, Takahashi D, Morikawa T, Koshida K, Komiyama S, Ishihara N, Yamada T, Kawamura YI, Muroi K, Hattori K, Kobayashi N, Fujimura Y, Hirota M, Matsumoto R, Aoki R, Tamura-Nakano M, Sugiyama M, Katakai T, Sato S, Takubo K, Dohi T, Hase K.

Cell. 2019 Aug 22;178(5):1072-1087.e14. doi: 10.1016/j.cell.2019.07.047.

PMID:
31442401
2.

Fecal metabolite of a gnotobiotic mouse transplanted with gut microbiota from a patient with Alzheimer's disease.

Fujii Y, Nguyen TTT, Fujimura Y, Kameya N, Nakamura S, Arakawa K, Morita H.

Biosci Biotechnol Biochem. 2019 Jul 22:1-9. doi: 10.1080/09168451.2019.1644149. [Epub ahead of print]

PMID:
31327302
3.

Cuprizone-treated mice, a possible model of schizophrenia, highlighting the simultaneous abnormalities of GABA, serine and glycine in hippocampus.

Hayakawa E, Ohgidani M, Fujimura Y, Kanba S, Miura D, Kato TA.

Schizophr Res. 2019 Aug;210:326-328. doi: 10.1016/j.schres.2019.06.010. Epub 2019 Jul 8. No abstract available.

PMID:
31296416
4.

Dynamic Stark-Induced Coherent π-Electron Rotations in a Chiral Aromatic Ring Molecule: Application to Phenylalanine.

Mineo H, Kim GS, Lin SH, Fujimura Y.

J Phys Chem A. 2019 Aug 1;123(30):6399-6410. doi: 10.1021/acs.jpca.9b03083. Epub 2019 Jul 22.

PMID:
31265291
5.

[Duodenal obstruction after transarterial embolization for rupture of a pancreaticoduodenal artery aneurysm due to segmental arterial mediolysis:a case report].

Goda K, Yo S, Katsumata R, Fukushima S, Osawa M, Murao T, Ishii M, Fujimura Y, Matsumoto H, Shiotani A.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(6):515-522. doi: 10.11405/nisshoshi.116.515. Japanese.

PMID:
31178581
6.

Isolated pancreatic metastasis from malignant melanoma: a case report and literature review.

Nakamura Y, Yamada R, Kaneko M, Naota H, Fujimura Y, Tabata M, Kobayashi K, Tanaka K.

Clin J Gastroenterol. 2019 May 27. doi: 10.1007/s12328-019-00996-6. [Epub ahead of print]

PMID:
31134450
7.

Development of an antibacterial bioactive dental adhesive: Simplicity and innovation.

Fujimura Y, Weerasinghe D, Kawashima M.

Am J Dent. 2018 Nov 15;31(Sp Is B):13B-16B. Review.

PMID:
31099207
8.

Involvement of the ADAMTS13-VWF axis in acute Kawasaki disease and effects of intravenous immunoglobulin.

Tsujii N, Nogami K, Matsumoto M, Yoshizawa H, Takase T, Tanaka I, Sakai T, Fukuda K, Hayakawa M, Sakai K, Isonishi A, Matsuura K, Fujimura Y, Shima M.

Thromb Res. 2019 Jul;179:1-10. doi: 10.1016/j.thromres.2019.04.026. Epub 2019 Apr 24.

PMID:
31055186
9.

Improvement of Sensitivity and Reproducibility for Imaging of Endogenous Metabolites by Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry.

Morikawa-Ichinose T, Fujimura Y, Murayama F, Yamazaki Y, Yamamoto T, Wariishi H, Miura D.

J Am Soc Mass Spectrom. 2019 Aug;30(8):1512-1520. doi: 10.1007/s13361-019-02221-7. Epub 2019 May 1.

PMID:
31044355
10.

Correction to: Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome.

Fujisawa M, Kato H, Yoshida Y, Usui T, Takata M, Fujimoto M, Wada H, Uchida Y, Kokame K, Matsumoto M, Fujimura Y, Miyata T, Nangaku M.

Clin Exp Nephrol. 2019 Jul;23(7):985. doi: 10.1007/s10157-019-01728-3.

11.

The utilization and challenges of Japan's MID-NET® medical information database network in postmarketing drug safety assessments: A summary of pilot pharmacoepidemiological studies.

Yamada K, Itoh M, Fujimura Y, Kimura M, Murata K, Nakashima N, Nakayama M, Ohe K, Orii T, Sueoka E, Suzuki T, Yokoi H, Ishiguro C, Uyama Y; MID-NET® project group.

Pharmacoepidemiol Drug Saf. 2019 May;28(5):601-608. doi: 10.1002/pds.4777. Epub 2019 Apr 3.

PMID:
30945387
12.

Blood group antigen A on von Willebrand factor is more protective against ADAMTS13 cleavage than antigens B and H.

Hayakawa M, Kato S, Matsui T, Sakai K, Fujimura Y, Matsumoto M.

J Thromb Haemost. 2019 Jun;17(6):975-983. doi: 10.1111/jth.14444. Epub 2019 May 6.

PMID:
30929293
13.

The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: Key findings at enrolment until 2017.

van Dorland HA, Mansouri Taleghani M, Sakai K, Friedman KD, George JN, Hrachovinova I, Knöbl PN, von Krogh AS, Schneppenheim R, Aebi-Huber I, Bütikofer L, Largiadèr CR, Cermakova Z, Kokame K, Miyata T, Yagi H, Terrell DR, Vesely SK, Matsumoto M, Lämmle B, Fujimura Y, Kremer Hovinga JA; Hereditary TTP Registry.

Haematologica. 2019 Feb 21. pii: haematol.2019.216796. doi: 10.3324/haematol.2019.216796. [Epub ahead of print]

14.

[A Case of Small Intestinal Neuroendocrine Tumor Detected One Year after Resection of Liver Metastasis].

Fujimura Y, Tabata M, Sakamoto T, Maeda K, Ohsawa I, Kato K, Iwata M, Sanda T.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2180-2182. Japanese.

PMID:
30692324
15.

Photometric Stereo in Participating Media Using an Analytical Solution for Shape-Dependent Forward Scatter.

Fujimura Y, Iiyama M, Hashimoto A, Minoh M.

IEEE Trans Pattern Anal Mach Intell. 2018 Dec 21. doi: 10.1109/TPAMI.2018.2889088. [Epub ahead of print]

PMID:
30582528
16.

Molecular Dynamics Simulation Study of Polyamide Membrane Structures and RO/FO Water Permeation Properties.

Yoshioka T, Kotaka K, Nakagawa K, Shintani T, Wu HC, Matsuyama H, Fujimura Y, Kawakatsu T.

Membranes (Basel). 2018 Dec 6;8(4). pii: E127. doi: 10.3390/membranes8040127.

17.

Diallyl disulfide potentiates anti-obesity effect of green tea in high-fat/high-sucrose diet-induced obesity.

Bae J, Kumazoe M, Fujimura Y, Tachibana H.

J Nutr Biochem. 2019 Feb;64:152-161. doi: 10.1016/j.jnutbio.2018.10.014. Epub 2018 Nov 3.

PMID:
30504007
18.

Upshaw-Schulman syndrome diagnosed during pregnancy complicated by reversible cerebral vasoconstriction syndrome.

Tsuda M, Shiratsuchi M, Nakashima Y, Ikeda M, Muta H, Narazaki T, Masuda T, Kimura D, Takamatsu A, Matsumoto M, Fujimura Y, Kokame K, Matsushima T, Ogawa Y.

Transfus Apher Sci. 2018 Dec;57(6):790-792. doi: 10.1016/j.transci.2018.10.023. Epub 2018 Nov 16.

PMID:
30471945
19.

Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{N-[(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2R)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate).

Kobayashi N, Sato N, Fujimura Y, Kihara T, Sugita K, Takahashi K, Koike K, Sugawara T, Tada Y, Nakai H, Yoshikawa T.

ACS Omega. 2018 Oct 31;3(10):13647-13666. doi: 10.1021/acsomega.8b01481. Epub 2018 Oct 19.

20.

Postprandial glycaemia-lowering effect of a green tea cultivar Sunrouge and cultivar-specific metabolic profiling for determining bioactivity-related ingredients.

Wasai M, Fujimura Y, Nonaka H, Kitamura R, Murata M, Tachibana H.

Sci Rep. 2018 Oct 30;8(1):16041. doi: 10.1038/s41598-018-34316-8.

21.

A variant at 9q34.11 is associated with HLA-DQB1*06:02 negative essential hypersomnia.

Miyagawa T, Khor SS, Toyoda H, Kanbayashi T, Imanishi A, Sagawa Y, Kotorii N, Kotorii T, Ariyoshi Y, Hashizume Y, Ogi K, Hiejima H, Kamei Y, Hida A, Miyamoto M, Ikegami A, Wada Y, Takami M, Higashiyama Y, Miyake R, Kondo H, Fujimura Y, Tamura Y, Taniyama Y, Omata N, Tanaka Y, Moriya S, Furuya H, Kato M, Kawamura Y, Otowa T, Miyashita A, Kojima H, Saji H, Shimada M, Yamasaki M, Kobayashi T, Misawa R, Shigematsu Y, Kuwano R, Sasaki T, Ishigooka J, Wada Y, Tsuruta K, Chiba S, Tanaka F, Yamada N, Okawa M, Kuroda K, Kume K, Hirata K, Uchimura N, Shimizu T, Inoue Y, Honda Y, Mishima K, Honda M, Tokunaga K.

J Hum Genet. 2018 Dec;63(12):1259-1267. doi: 10.1038/s10038-018-0518-8. Epub 2018 Sep 28.

PMID:
30266950
23.

Quantum Design for Ultrafast Probing of Molecular Chirality through Enantiomer-Specific Coherent π-Electron Angular Momentum.

Mineo H, Kim GS, Lin SH, Fujimura Y.

J Phys Chem Lett. 2018 Sep 20;9(18):5521-5526. doi: 10.1021/acs.jpclett.8b02137. Epub 2018 Sep 11.

PMID:
30192143
24.

Cultivable butyrate-producing bacteria of elderly Japanese diagnosed with Alzheimer's disease.

Nguyen TTT, Fujimura Y, Mimura I, Fujii Y, Nguyen NL, Arakawa K, Morita H.

J Microbiol. 2018 Oct;56(10):760-771. doi: 10.1007/s12275-018-8297-7. Epub 2018 Aug 22.

PMID:
30136260
25.

The number of CD34+CD133+ hematopoietic stem cells residing in umbilical cord blood (UCB) units is not correlated with the numbers of total nucleated cells and CD34+ cells: a possible new indicator for quality evaluation of UCB units.

Matsuoka Y, Nakamura F, Hatanaka K, Fujioka T, Otani S, Kimura T, Fujimura Y, Asano H, Sonoda Y.

Int J Hematol. 2018 Dec;108(6):571-579. doi: 10.1007/s12185-018-2502-7. Epub 2018 Jul 25.

PMID:
30046987
26.

Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.

Ito S, Hidaka Y, Inoue N, Kaname S, Kato H, Matsumoto M, Miyakawa Y, Mizuno M, Okada H, Shimono A, Matsuda T, Maruyama S, Fujimura Y, Nangaku M, Kagami S.

Clin Exp Nephrol. 2019 Jan;23(1):112-121. doi: 10.1007/s10157-018-1610-2. Epub 2018 Jul 23.

27.

Visualizing Energy Charge in Breast Carcinoma Tissues by MALDI Mass-spectrometry Imaging Profiles of Low-molecular-weight Metabolites.

Torata N, Kubo M, Miura D, Ohuchida K, Mizuuchi Y, Fujimura Y, Hayakawa E, Kai M, Oda Y, Mizumoto K, Hashizume M, Nakamura M.

Anticancer Res. 2018 Jul;38(7):4267-4272. doi: 10.21873/anticanres.12723.

PMID:
29970560
28.

Safety and effectiveness of eculizumab for adult patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.

Kato H, Miyakawa Y, Hidaka Y, Inoue N, Ito S, Kagami S, Kaname S, Matsumoto M, Mizuno M, Matsuda T, Shimono A, Maruyama S, Fujimura Y, Nangaku M, Okada H.

Clin Exp Nephrol. 2019 Jan;23(1):65-75. doi: 10.1007/s10157-018-1609-8. Epub 2018 Jun 29.

29.

Comparison of osseous healing after sagittal split ramus osteotomy and intraoral vertical ramus osteotomy.

Rokutanda S, Yamada S, Yanamoto S, Omori K, Fujimura Y, Morita Y, Rokutanda H, Kohara H, Fujishita A, Nakamura T, Yoshimi T, Yoshida N, Umeda M.

Int J Oral Maxillofac Surg. 2018 Oct;47(10):1316-1321. doi: 10.1016/j.ijom.2018.05.013. Epub 2018 May 26.

PMID:
29843949
30.

Efficacy and safety of sodium-glucose cotransporter 2 inhibitor ipragliflozin on glycemic control and cardiovascular parameters in Japanese patients with type 2 diabetes mellitus; Fukuoka Study of Ipragliflozin (FUSION).

Nomiyama T, Shimono D, Horikawa T, Fujimura Y, Ohsako T, Terawaki Y, Fukuda T, Motonaga R, Tanabe M, Yanase T; Collaborators of Fukuoka Study of Ipragliflozin (FUSION) trial.

Endocr J. 2018 Aug 27;65(8):859-867. doi: 10.1507/endocrj.EJ18-0022. Epub 2018 May 26.

31.

Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome.

Abe I, Sugimoto K, Miyajima T, Ide T, Minezaki M, Takeshita K, Takahara S, Nakagawa M, Fujimura Y, Kudo T, Miyajima S, Taira H, Ohe K, Ishii T, Yanase T, Kobayashi K.

Intern Med. 2018 Sep 1;57(17):2467-2472. doi: 10.2169/internalmedicine.0550-17. Epub 2018 Apr 27.

32.

Lifestyle and overall health in high school children: Results from the Toyama birth cohort study, Japan.

Li W, Sekine M, Yamada M, Fujimura Y, Tatsuse T.

Pediatr Int. 2018 May;60(5):467-473. doi: 10.1111/ped.13548.

PMID:
29513391
33.

Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome.

Fujisawa M, Kato H, Yoshida Y, Usui T, Takata M, Fujimoto M, Wada H, Uchida Y, Kokame K, Matsumoto M, Fujimura Y, Miyata T, Nangaku M.

Clin Exp Nephrol. 2018 Oct;22(5):1088-1099. doi: 10.1007/s10157-018-1549-3. Epub 2018 Mar 6. Erratum in: Clin Exp Nephrol. 2019 Apr 23;:.

34.

Alternative pathway activation due to low level of complement factor H in primary antiphospholipid syndrome.

Nakamura H, Oku K, Ogata Y, Ohmura K, Yoshida Y, Kitano E, Fujieda Y, Kato M, Bohgaki T, Amengual O, Yasuda S, Fujimura Y, Seya T, Atsumi T.

Thromb Res. 2018 Apr;164:63-68. doi: 10.1016/j.thromres.2018.02.142. Epub 2018 Feb 21.

PMID:
29494857
35.

Intravitreal injection of aflibercept, an anti-VEGF antagonist, down-regulates plasma von Willebrand factor in patients with age-related macular degeneration.

Yamashita M, Matsumoto M, Hayakawa M, Sakai K, Fujimura Y, Ogata N.

Sci Rep. 2018 Jan 24;8(1):1491. doi: 10.1038/s41598-018-19473-0.

36.

[A Resected Case of UR-LA Pancreatic Tail Cancer with Aortic Invasion after Chemoradiotherapy].

Fujimura Y, Tabata M, Sakamoto T, Maeda K, Ohsawa I, Kato K, Iwata M, Sanda T.

Gan To Kagaku Ryoho. 2018 Jan;45(1):151-153. Japanese.

PMID:
29362338
37.

Acute vascular reaction due to lipo-prostaglandin E1.

Fujimura Y, Watanabe M, Natsuga K, Shimizu H.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e273-e274. doi: 10.1111/jdv.14807. Epub 2018 Feb 6. No abstract available.

PMID:
29356126
38.

Analysis of spatiotemporal metabolomic dynamics for sensitively monitoring biological alterations in cisplatin-induced acute kidney injury.

Irie M, Hayakawa E, Fujimura Y, Honda Y, Setoyama D, Wariishi H, Hyodo F, Miura D.

Biochem Biophys Res Commun. 2018 Jan 29;496(1):140-146. doi: 10.1016/j.bbrc.2018.01.012. Epub 2018 Jan 4.

PMID:
29307833
39.

Severe reduction of free-form ADAMTS13, unbound to von Willebrand factor, in plasma of patients with HELLP syndrome.

Yoshida Y, Matsumoto M, Yagi H, Isonishi A, Sakai K, Hayakawa M, Hori Y, Sado T, Kobayashi H, Fujimura Y.

Blood Adv. 2017 Aug 23;1(20):1628-1631. doi: 10.1182/bloodadvances.2017006767. eCollection 2017 Sep 12.

40.

Quantum control of coherent π-electron ring currents in polycyclic aromatic hydrocarbons.

Mineo H, Fujimura Y.

J Chem Phys. 2017 Dec 14;147(22):224301. doi: 10.1063/1.5004504.

PMID:
29246044
41.

Highly elevated plasma level of von Willebrand factor accelerates the formation of platelet thrombus under high shear stress in plasma with deficient ADAMTS13 activity.

Yagi H, Yamaguchi N, Shida Y, Sugimoto M, Tubaki K, Fujimura Y, Matsumoto M.

Thromb Res. 2017 Nov;159:91-95. doi: 10.1016/j.thromres.2017.10.007. Epub 2017 Oct 10.

PMID:
29040872
42.

A Phytochemical-Sensing Strategy Based on Mass Spectrometry Imaging and Metabolic Profiling for Understanding the Functionality of the Medicinal Herb Green Tea.

Fujimura Y, Miura D, Tachibana H.

Molecules. 2017 Sep 27;22(10). pii: E1621. doi: 10.3390/molecules22101621. Review.

43.

Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.

Scully M, Knöbl P, Kentouche K, Rice L, Windyga J, Schneppenheim R, Kremer Hovinga JA, Kajiwara M, Fujimura Y, Maggiore C, Doralt J, Hibbard C, Martell L, Ewenstein B.

Blood. 2017 Nov 9;130(19):2055-2063. doi: 10.1182/blood-2017-06-788026. Epub 2017 Sep 14.

44.

Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure.

Takaya H, Yoshiji H, Kawaratani H, Sakai K, Matsumoto M, Fujimura Y, Fukui H.

Biomed Rep. 2017 Sep;7(3):277-285. doi: 10.3892/br.2017.945. Epub 2017 Jul 19.

45.

Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients.

Fujimura Y, Yamauchi Y, Murase T, Nakamura T, Fujita SI, Fujisaka T, Ito T, Sohmiya K, Hoshiga M, Ishizaka N.

PLoS One. 2017 Aug 10;12(8):e0182699. doi: 10.1371/journal.pone.0182699. eCollection 2017.

46.

Type XVII collagen coordinates proliferation in the interfollicular epidermis.

Watanabe M, Natsuga K, Nishie W, Kobayashi Y, Donati G, Suzuki S, Fujimura Y, Tsukiyama T, Ujiie H, Shinkuma S, Nakamura H, Murakami M, Ozaki M, Nagayama M, Watt FM, Shimizu H.

Elife. 2017 Jul 11;6. pii: e26635. doi: 10.7554/eLife.26635.

47.

Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) 2017 in Japan.

Matsumoto M, Fujimura Y, Wada H, Kokame K, Miyakawa Y, Ueda Y, Higasa S, Moriki T, Yagi H, Miyata T, Murata M; For TTP group of Blood Coagulation Abnormalities Research Team, Research on Rare and Intractable Disease supported by Health, Labour, and Welfare Sciences Research Grants.

Int J Hematol. 2017 Jul;106(1):3-15. doi: 10.1007/s12185-017-2264-7. Epub 2017 May 26.

PMID:
28550351
48.

A Chemometrics-driven Strategy for the Bioactivity Evaluation of Complex Multicomponent Systems and the Effective Selection of Bioactivity-predictive Chemical Combinations.

Fujimura Y, Kawano C, Maeda-Murayama A, Nakamura A, Koike-Miki A, Yukihira D, Hayakawa E, Ishii T, Tachibana H, Wariishi H, Miura D.

Sci Rep. 2017 May 23;7(1):2257. doi: 10.1038/s41598-017-02499-1.

49.

Correction: A Novel Quantitative Hemolytic Assay Coupled with Restriction Fragment Length Polymorphisms Analysis Enabled Early Diagnosis of Atypical Hemolytic Uremic Syndrome and Identified Unique Predisposing Mutations in Japan.

Yoshida Y, Miyata T, Matsumoto M, Shirotani-Ikejima H, Uchida Y, Ohyama Y, Kokubo T, Fujimura Y.

PLoS One. 2017 May 16;12(5):e0178015. doi: 10.1371/journal.pone.0178015. eCollection 2017.

50.

Implementation of a rapid assay of ADAMTS13 activity was associated with improved 30-day survival rate in patients with acquired primary thrombotic thrombocytopenic purpura who received platelet transfusions.

Yoshii Y, Fujimura Y, Bennett CL, Isonishi A, Kurumatani N, Matsumoto M.

Transfusion. 2017 Aug;57(8):2045-2053. doi: 10.1111/trf.14152. Epub 2017 May 12.

PMID:
28500622

Supplemental Content

Loading ...
Support Center